Wells Fargo Downgrades Nevro to Underweight, Lowers Price Target to $5.5
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo has downgraded Nevro (NYSE:NVRO) from Equal-Weight to Underweight and lowered its price target from $13 to $5.5.
August 07, 2024 | 12:52 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Wells Fargo has downgraded Nevro from Equal-Weight to Underweight and significantly lowered its price target from $13 to $5.5.
The downgrade from Equal-Weight to Underweight and the significant reduction in the price target from $13 to $5.5 by Wells Fargo is likely to negatively impact Nevro's stock price in the short term. This indicates a lack of confidence in the company's near-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100